MedPath

Comparision of potency of muscle relaxant â??vecuroniumâ?? during isoflurane anesthesia and nitrous oxide anesthesia

Not Applicable
Conditions
Health Condition 1: null- ASA1 and 2 patients, of age between 18-65yrs ,undergoing surgery for more than 1 hr
Registration Number
CTRI/2018/03/012704
Lead Sponsor
Jawaharlal institute of postgraduate education and research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Adult patients undergoing elective surgical procedures of more than one hour duration, requiring general anesthesia with muscle relaxation

Exclusion Criteria

1. Patientâ??s refusal.

2. Patients with hepatic or renal dysfunction.

3. Patients with neuromuscular disorders.

4. Patients on medication that may alter neuromuscular transmission.

5.Pregnant patients and patients above 65 years of age.

6. Contraindication to nitrous oxide, isoflurane or vecuronium

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
sing neuro muscular monitoring,To assess and compare neuromuscular blockade of vecuronium during general anaesthesia with O2,N2O and isoflurane versus O2,air and isoflurane.Timepoint: PTC1-TOF1
Secondary Outcome Measures
NameTimeMethod
sing neuro muscular monitoring,To assess and compare 1. block onset time of vecuronium in both the groups using the time taken for twitch height depression to become 30% of normal <br/ ><br>2. from vecuronium administration to first appearance of PTC 1 <br/ ><br>3. PTC (n) at reappearance of 1st twitch in both the groups <br/ ><br>4.time interval between TOF 1 and TOF 3 <br/ ><br> 5.from vecuronium administration to appearance of TOF 3Timepoint: post tetanic count-1(PTC1), Train of four-TOF1,TOF3,TOF1-TOF3.
© Copyright 2025. All Rights Reserved by MedPath